87 天前 - … evidence that VTE is often a chronic disease associated with a high risk of recurrence
and chronic sequelae. The COVID-19 … more widespread use of thromboprophylaxis, the …

114 天前 - … , required further investigation and confirmation through rigorous evidence studies.
… explore the appropriate dose for thromboprophylaxis in hospitalized COVID-19 patients, the …

201 天前 - … more severe disease noted in succeeding waves of the pandemic, there was no
significant evidence of COVID-19… inviting further debate as to the degree of thromboprophylaxis …

240 天前 - Background: Recent international guidelines recommend treatment without antibiotics
for uncomplicated diverticulitis (UD). We assessed physicians’ current knowledge and …

262 天前 - … receiving usual-care pharmacologic thromboprophylaxis (3.4% vs 3.9%). …
COVID-19–associated AKI. This precaution should be taken while awaiting more conclusive …

267 天前 - … However, robust evidence is still lacking because this was mainly based on
retrospective … Lastly, contrary to what occurs in nonCOVID-19 patients, thromboprophylaxis is not …

318 天前 - … doses of low molecular weight heparin in COVID-19 patients, especially in the most
severe … of heparin as thromboprophylaxis in critically hospitalized COVID-19 patients and …

325 天前 - … with limited evidence on the impact of previous mild, asymptomatic COVID-19
infection, or … Standard thromboprophylaxis was used for all patients (intraoperative intermittent …

330 天前 - … Throughout the COVID-19 pandemic, clinicians have … This paper seeks to examine
current available evidence and … standard thromboprophylaxis for COVID-19 patients in the …

337 天前 - … investigating enoxaparin thromboprophylaxis in COVID-19 symptomatic outpatients.
… In conclusion, we found no evidence of a clinical advantage of administering prophylactic …